Emergent BioSolutions | DEBITO



Debt Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 622.82M 1.27M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Exact Sciences USD 2.34B 250.85M 2025-03
Exelixis USD 0 0 2025-04
Glaxosmithkline GBP 16.99B 927M 2024-12
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lonza CHF 4.71B 915M 2024-12
Merck USD 34.84B 2.27B 2025-03
Moderna USD 745M 683M 2025-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Pacira USD 583.38M 1.94M 2025-03
Pfizer USD 62.11B 2.24B 2025-03
PTC Therapeutics USD 2.4B 17.29M 2025-03
Sanofi 21.05B 3.14B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
United Therapeutics USD 200M 100M 2025-03



Emergent BioSolutions DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.